Data Caveats Delay

The primary endpoint is statistically positive, but investors later focus on caveats in secondary endpoints, durability or tolerability. This would not invalidate the drug, but it could delay filings or narrow the eventual label.

Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.